Prevention of ovarian cancer

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 20, Issue 2, 2006, Pages 339-362

  Hanna, Louise ^a   Adams, Malcolm ^a  

^a VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

Lifestyle; Ovarian cancer; Prevention; Prophylactic surgery; Risk factors

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; AROMATIC AMINE; ASBESTOS; ASCORBIC ACID; BRCA1 PROTEIN; BRCA2 PROTEIN; CAFFEINE; CALCIUM; CARBOHYDRATE; CAROTENE; CAROTENOID; CORN OIL; CYCLOOXYGENASE 2 INHIBITOR; FENRETINIDE; HORMONE DERIVATIVE; INDUSTRIAL CHEMICAL; LYCOPENE; NONSTEROID ANTIINFLAMMATORY AGENT; OLIVE OIL; ORAL CONTRACEPTIVE AGENT; PESTICIDE; PHYTOESTROGEN; RETINOL; SUNFLOWER OIL; UNINDEXED DRUG; VITAMIN B GROUP; VITAMIN D; XANTHOPHYLL; ZEAXANTHIN;

ACADEMIC ACHIEVEMENT; ALCOHOL CONSUMPTION; BODY HEIGHT; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CARCINOGENESIS; CIGARETTE SMOKING; COLORECTAL CANCER; DIETARY FIBER; EGG; ENVIRONMENTAL FACTOR; EXERCISE; FAMILY HISTORY; FAT INTAKE; FEMALE; FEMALE INFERTILITY; FISH; FOOD INTAKE; FRUIT; GENE MUTATION; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; LACTATION; LIFESTYLE; MEAT; MENSTRUATION; MILK; OBESITY; OVARIECTOMY; OVARY CANCER; PHYSICAL ACTIVITY; POULTRY; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SALPINGOOOPHORECTOMY; SMOKING CESSATION; SOCIAL STATUS; TREATMENT OUTCOME; UTERINE TUBE LIGATION; VEGETABLE; WEIGHT CONTROL;

CONTRACEPTIVES, ORAL, HORMONAL; DIET; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE STYLE; OVARIAN NEOPLASMS; OVARIECTOMY; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 33644896800     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2005.10.016     Document Type: Review

References (132)

1. F. Bray A.H. Loos S. Tognazzo C. La Vecchia Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000 International Journal of Cancer 113 2005 977-990
2. J.T. Quirk N. Natarajan Ovarian cancer incidence in the United States, 1992-1999 Gynecologic Oncology 97 2005 519-523
3. A.P. Heintz N.F. Hacker L.D. Lagasse Epidemiology and etiology of ovarian cancer: A review Obstetrics and Gynecology 66 1985 127-135
4. K. Hemminki X. Li Cancer risks in second-generation immigrants to Sweden International Journal of Cancer 99 2002 229-237
5. S. Gnagy E.E. Ming S.S. Devesa et al. Declining ovarian cancer rates in US women in relation to parity and oral contraceptive use Epidemiology 11 2000 102-105
6. F. Modugno Ovarian cancer and high-risk women-implications for prevention, screening, and early detection Gynecologic Oncology 91 2003 15-31
7. D.M. Purdie C.J. Bain V. Siskind et al. Ovulation and risk of epithelial ovarian cancer International Journal of Cancer 104 2003 228-232
8. D.W. Cramer W.R. Welch Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis Journal of the National Cancer Institute 71 1983 717-721
9. H.A. Risch Hormonal etiology of epithelial ovarian cancer, with hypothesis concerning the role of androgens and progesterone Journal of the National Cancer Institute 90 1998 1774-1786
10. R.B. Ness C. Cottreau Possible role of ovarian epithelial inflammation in ovarian cancer Journal of the National Cancer Institute 91 1999 1459-1467
11. D.W. Cramer R.L. Barbieri A.R. Fraer B.L. Harlow Determinants of early follicular phase gonadotrophin and estradiol concentrations in women of late reproductive age Human Reproduction 17 2002 221-227
12. S. Greggi F. Parazzini M.P. Paratore et al. Risk factors for ovarian cancer in central Italy Gynecologic Oncology 79 2000 50-54
13. F. Parazzini E. Negri C. La Vecchia et al. Family history of reproductive cancers and ovarian cancer risk: An Italian case-control study American Journal of Epidemiology 135 1992 35-40
14. A. Tavani E. Negri S. Franceschi et al. Risk factors for epithelial ovarian cancer in women under age 45 European Journal of Cancer 29A 1993 1297-1301
15. P.J. Mink A.R. Folsom T.A. Sellers L.H. Kushi Physical activity, waist-to-hip ratio, and other risk factors for ovarian cancer: A follow-up study of older women Epidemiology 7 1996 38-45
16. K. Kerlikowske J.S. Brown D.G. Grady Should women with familial ovarian cancer undergo prophylactic oophorectomy? Obstetrics and Gynecology 80 1992 700-707
17. E. Negri C. Pelucchi S. Franceschi et al. Family history of cancer and risk of ovarian cancer European Journal of Cancer 39 2003 505-510
18. A.W. Kurian R.R. Balise V. McGuire A.S. Whittemore Histologic types of epithelial ovarian cancer: Have they different risk factors? Gynecologic Oncology 96 2005 520-530
19. H.A. Risch J.R. McLaughlin D.E. Cole et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer American Journal of Human Genetics 68 2001 700-710
20. T.S. Frank S.A. Manley O.I. Olopade et al. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk Journal of Clinical Oncology 16 1998 2417-2425
21. A.C. Antoniou S.A. Gayther J.F. Stratton et al. Risk models for familial ovarian and breast cancer Genetic Epidemiology 18 2000 173-190
22. J.P. Struewing P. Hartge S. Wacholder et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews The New England Journal of Medicine 336 1997 1401-1408
23. A. Antoniou P.D. Pharoah S. Narod et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies American Journal of Human Genetics 72 2003 1117-1130
24. K.A. Metcalfe H.T. Lynch P. Ghadirian et al. The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers Obstetrical and Gynecological Survey 60 2005 235-236
25. R.P. Zweemer R.H. Verheijen J.J. Gille et al. Clinical and genetic evaluation of thirty ovarian cancer families American Journal of Obstetrics and Gynecology 178 1998 85-90
26. J. Chang I. Fryatt B. Ponder et al. A matched control study of familial epithelial ovarian cancer: Patient characteristics, response to chemotherapy and outcome Annals of Oncology 6 1995 80-82
27. B.A. Werness S.J. Ramus R.A. DiCioccio et al. stage, and BRCA mutation status of ovarian cancers from the gilda radner familial ovarian cancer registry International Journal of Gynecological Pathology 23 2004 29-34
28. P.A. Shaw J.R. McLaughlin R.P. Zweemer et al. Histopathologic features of geneticaly determined ovarian cancer International Journal of Gynecological Pathology 21 2002 407-411
29. S.R. Lakhani S. Manek F. Penault-Llorca et al. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers Clinical Cancer Research 10 2004 2473-2481
30. J. Boyd Y. Sonoda M.G. Federici et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer The Journal of the American Medical Association 283 2000 2260-2265
31. K.H. Lu M. Dinh W. Kohlmann et al. Gynacologic cancer as a 'sentinal cancer' for women with hereditary nonpolyposis colorectal cancer syndrome Obstetrics and Gynecology 105 2005 569-574
32. K.H. Tung M.T. Goodman A.H. Wu et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: A multiethnic case-control study American Journal of Epidemiology 158 2003 629-638
33. L. Titus-Ernstoff K. Perez D.W. Cramer et al. Menstrual and reproductive factors in relation to ovarian cancer risk British Journal of Cancer 84 2001 714-721
34. F. Chiaffarino C. Pelucchi F. Parazzini et al. Reproductive and hormonal factors and ovarian cancer Annals of Oncology 12 2001 337-341
35. T. Riman P.W. Dickman S. Nilsson et al. Risk factors for invasive epithelial ovarian cancer: Results from a Swedish case-control study American Journal of Epidemiology 156 2001 363-373
36. F. Lubin A. Chetrit L.S. Freedman et al. Body mass index at age 18 years and during adult life and ovarian cancer risk American Journal of Epidemiology 157 2003 113-120
37. S. Franceschi C. La Vecchia M. Booth et al. Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause International Journal of Cancer 49 1991 57-60
38. J.M. Schildkraut G.S. Cooper S. Halabi et al. Age at natural menopause and the risk of epithelial ovarian cancer Obstetrics and Gynecology 98 2001 85-90
39. M. Zhang A.H. Lee C.W. Binns Reproductive and dietary risk factors for epithelial ovarian cancer in China Gynecologic Oncology 92 2004 320-326
40. B. Modan P. Hartge G. Hirsh-Yechezkel et al. Parity, oral contraceptive, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation The New England Journal of Medicine 345 2001 235-240
41. F. Parazzini F. Chiaffarino E. Negri et al. Risk factors for different histological types of ovarian cancer International Journal of Gynecological Cancer 14 2004 431-436
42. D.M. Purdie V. Siskind C.J. Bain et al. Reproduction-related risk factors for mucinous and nonmucinous epithelial ovarian cancer American Journal of Epidemiology 153 2001 860-864
43. V. McGuire A. Felberg M. Mills et al. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations American Journal of Epidemiology 160 2004 613-618
44. V. Siskind A. Green C. Bain D. Purdie Breastfeeding, menopause, and epithelial ovarian cancer Epidemiology 8 1997 188-191
45. R.B. Ness D.W. Cramer M.T. Goodman et al. Infertility, fertility drugs, and ovarian cancer: A pooled analysis of case-control studies American Journal of Epidemiology 155 2001 217-224
46. L.A. Brinton E.J. Lamb K.S. Moghissi et al. Ovarian cancer risk after the use of ovulation-stimulating drugs Obstetrics and Gynecology 103 2004 1194-1203
47. F. Modugno R.B. Ness G.O. Allen et al. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis American Journal of Obstetrics and Gynecology 191 2004 733-740
48. C. Bosetti E. Negri D. Trichopoulos et al. Long-term effects of oral contraceptives on ovarian cancer risk International Journal of Cancer 102 2002 262-265
49. M. Kumle E. Weiderpass T. Braaten et al. Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: The Norwegian-Swedish women's lifestyle and health cohort study British Journal of Cancer 90 2004 1386-1391
50. K.H. Tung L.R. Wilkens A.H. Wu et al. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: Revisiting the incessant ovulation hypothesis American Journal of Epidemiology 161 2005 321-329
51. G.R. Walker J.J. Schlesselman R.B. Ness Family history of cancer, oral contraceptive use, and ovarian cancer risk American Journal of Obstetrics and Gynecology 186 2002 8-14
52. J. Royar H. Becher J. Chang-Claude Low-dose oral contraceptives: protective effect on ovarian cancer risk International Journal of Cancer 95 2001 370-374
53. R.B. Ness J.A. Grisso R. Vergona et al. Oral contraceptives, other methods of contraception, and risk reduction for ovarian cancer Epidemiology 12 2001 307-312
54. J.B. Greer F. Modugno G.O. Allen R.B. Ness Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer Obstetrics and Gynecology 105 2005 731-740
55. J.M. Schildkraut B. Calingaert P.A. Marchbanks et al. Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk Journal of the National Cancer Institute 94 2002 32-38
56. M. Vessey R. Painter D. Yeates Mortality in relation to oral contraceptive use and cigarette smoking Lancet 362 2003 185-191
57. V. Beral C. Hermon C. Kay et al. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from royal college of general practitioners' oral contraception study British Medical Journal 318 1999 96-100
58. Anonymous Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative group on hormonal factors in breast cancer Lancet 347 1996 1713-1727
59. S.A. Narod H. Risch R. Moslehi et al. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary ovarian cancer clinical study group The New England Journal of Medicine 339 1998 424-428
60. A.S. Whittemore R.R. Balise P.D. Pharoah et al. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations British Journal of Cancer 91 2004 1911-1915
61. G. Ursin B.E. Henderson R.W. Haile et al. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? Cancer Research 57 1997 3678-3681
62. S.A. Narod M.P. Dube J. Klijn et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers Journal of the National Cancer Institute 94 2002 1773-1779
63. R.L. Milne J.A. Knight E.M. John et al. Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations Cancer Epidemiology Biomarkers and Prevention 14 2005 350-356
64. C. Rodriguez A.V. Patel E.E. Calle et al. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women The Journal of the American Medical Association 285 2001 1460-1465
65. T. Riman P.W. Dickman S. Nilsson et al. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women Journal of the National Cancer Institute 94 2002 497-504
66. J.V. Jr. Lacey P.J. Mink J.H. Lubin et al. Menopausal hormone replacement therapy and risk of ovarian cancer The Journal of the American Medical Association 288 2002 334-341
67. G.C. Zografos M. Panou N. Panou Common risk factors of breast and ovarian cancer: Recent view International Journal of Gynecological Cancer 14 2004 721-740
68. S.E. McCann K.B. Moysich C. Mettlin Intakes of selected nutrients and food groups and risk of ovarian cancer Nutrition and Cancer 39 2001 19-28
69. S.E. McCann J.L. Freudenheim J.R. Marshall S. Graham Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups The Journal of Nutrition 133 2003 1937-1942
70. D.W. Cramer H. Kuper B.L. Harlow L. Titus-Ernstoff Carotenoids, antioxidants and ovarian cancer risk in pre- and postmenopausal women International Journal of Cancer 94 2001 128-134
71. E. Bidoli C. La Vecchia R. Talamini et al. Micronutrients and ovarian cancer: A case-control study in Italy Annals of Oncology 12 2001 1589-1593
72. S.Y. Pan A.M. Ugnat Y. Mao et al. A case-control study of diet and the risk of ovarian cancer Cancer Epidemiology Biomarkers and Prevention 13 2004 1521-1527
73. K.M. Fairfield S.E. Hankinson B.A. Rosner et al. Risk of ovarian carcinoma and consumption of vitamins A, C, and E and specific carotenoids: A prospective analysis Cancer 92 2001 2318-2326
74. K.H. Tung L.R. Wilkens A.H. Wu et al. Association of dietary vitamin A, carotenoids, and other antioxidants with the risk of ovarian cancer Cancer Epidemiology Biomarkers and Prevention 14 2005 669-676
75. A.T. Fleischauer S.H. Olson L. Mignone et al. Dietary antioxidants, supplements, and risk of epithelial ovarian cancer Nutrition and Cancer 40 2001 92-98
76. E. Salazar-Martinez E.C. Lazcano-Ponce G. Gonzalez Lira-Lira et al. Nutritional determinants of epithelial ovarian cancer risk: A case-control study in Mexico Oncology 63 2002 151-157
77. C. Bosetti E. Negri S. Franceschi et al. Diet and ovarian cancer risk: a case-control study in Italy International Journal of Cancer 93 2001 911-915
78. E.R. Bertone B.A. Rosner D.J. Hunter et al. Dietary fat intake and ovarian cancer in a cohort of US women American Journal of Epidemiology 156 2002 22-31
79. M.T. Goodman A.H. Wu K.H. Tung et al. Association of dairy products, lactose, and calcium with the risk of ovarian cancer American Journal of Epidemiology 156 2002 148-157
80. S.C. Larsson L. Bergkvist A. Wolk Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort The American Journal of Clinical Nutrition 80 2004 1353-1357
81. C. Bosetti E. Negri S. Franceschi et al. Olive oil, seed oils and other added fats in relation to ovarian cancer (Italy) Cancer Causes and Control 13 2002 465-470
82. X.M. Li D. Ganmaa A. Sato The experience of Japan as a clue to the etiology of breast and ovarian cancers: Relationship between death from both malignancies and dietary practices Medical Hypotheses 60 2003 268-275
83. M. Huncharek B. Kupelnick Dietary fat intake and risk of epithelial ovarian cancer: A meta-analysis of 6689 subjects from 8 observational studies Nutrition and Cancer 40 2001 87-91
84. E. Bidoli C. La Vecchia M. Montella et al. Nutrient intake and ovarian cancer: An Italian case-control study Cancer Causes and Control 13 2002 255-261
85. L.J. Schouten M.P. Zeegers R.A. Goldbohm Alcohol and ovarian cancer risk: Results from the Netherlands Cohort Study Cancer Causes and Control 15 2004 201-209
86. T. Riman P.W. Dickman S. Nilsson et al. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women European Journal of Epidemiology 19 2004 1011-1019
87. L.E. Kelemen T.A. Sellers R.A. Vierkant et al. Association of folate and alcohol with risk of ovarian cancer in a prospective study of postmenopausal women Cancer Causes and Control 15 2004 1085-1093
88. F. Modugno R.B. Ness G.O. Allen Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer Obstetrics and Gynecology 102 2003 1336-1343
89. P.M. Webb D.M. Purdie C.J. Bain A.C. Green Alcohol, wine, and risk of epithelial ovarian cancer Cancer Epidemiology Biomarkers and Prevention 13 2004 592-599
90. H. Kuper L. Titus-Ernstoff B.L. Harlow D.W. Cramer Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer International Journal of Cancer 88 2000 313-318
91. M.T. Goodman K.H. Tung K. McDuffie et al. Association of caffeine intake and CYP1A2 genotype with ovarian cancer Nutrition and Cancer 46 2003 23-29
92. S.J. Jordan D.M. Purdie A.C. Green P.M. Webb Coffee, tea and caffeine and risk of epithelial ovarian cancer Cancer Causes and Control 15 2004 359-365
93. P.D. Terry A.B. Miller J.G. Jones T.E. Rohan Cigarette smoking and the risk of invasive epithelial ovarian cancer in a prospective cohort study European Journal of Cancer 39 2003 1157-1164
94. L.M. Hannan M.F. Leitzmann J.V. Lacey Jr et al. Physical activity and risk of ovarian cancer: A prospective cohort study in the United States Cancer Epidemiology Biomarkers and Prevention 13 2004 765-770
95. A. Tavani S. Gallus C. La Vecchia et al. Physical activity and risk of ovarian cancer: An Italian case-control study International Journal of Cancer 91 2001 407-411
96. E.R. Bertone P.A. Newcomb W.C. Willett et al. Recreational physical activity and ovarian cancer in a population-based case-control study International Journal of Cancer 99 2002 431-436
97. E.R. Bertone W.C. Willett B.A. Rosner et al. Prospective study of recreational physical activity and ovarian cancer Journal of the National Cancer Institute 93 2001 942-948
98. J.P. Anderson J.A. Ross A.R. Folsom Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa women's health study Cancer 100 2004 1515-1521
99. T. Shields G. Gridley T. Moradi et al. Occupational exposures and the risk of ovarian cancer in Sweden American Journal of Industrial Medicine 42 2002 200-213
100. M.A. Bulbulyan S.A. Ilychova S.H. Zahm et al. Cancer mortality among women in the Russian printing industry American Journal of Industrial Medicine 36 1999 166-171
101. Y. Wang E.L. Lewis-Michl S.A. Hwang et al. Cancer incidence among a cohort of female farm residents in New York State Archives of Environmental Health 57 2002 561-567
102. J. Guo T. Kauppinen P. Kyyronen et al. Risk of esophageal, ovarian, testicular, kidney and bladder cancers and leukemia among finnish workers exposed to diesel or gasoline engine exhaust International Journal of Cancer 111 2004 286-292
103. K. Vasama-Neuvonen E. Pukkala H. Paakkulainen et al. Ovarian cancer and occupational exposures in Finland American Journal of Industrial Medicine 36 1999 83-89
104. H. Langseth K. Kjaerheim Ovarian cancer and occupational exposure among pulp and paper employees in Norway Scandinavian Journal of Work Environment and Health 30 2004 356-361
105. A. Donna P. Crosignani F. Robutti et al. Triazine herbicides and ovarian epithelial neoplasms Scandinavian Journal of Work Environment and Health 15 1989 47-53
106. C. Hopenhayn-Rich M.L. Stump S.R. Browning et al. Regional assessment of atrazine exposure and incidence of breast and ovarian cancers in Kentucky Archives of Environmental contamination and Toxicology 42 2002 127-136
107. D.M. Freedman M. Dosemeci K. McGlynn Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: A composite death certificate based case-control study Occupation and Environmental Medicine 59 2002 257-262
108. Ferlay J, Bray F, Pisani P, & Parkin DM. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, Version 1.0 ed. IARC CancerBase No. 5. Lyon: IARC Press, 2001.
109. F. Faggiano T. Partanen M. Kogevinas P. Boffetta Socioeconomic differences in cancer incidence and mortality IARC Scientific Publications 138 1997 65-176
110. L.J. Schouten R.A. Goldbohm P.A. van den Brandt Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer American Journal of Epidemiology 157 2003 424-433
111. C. Rodriguez E.E. Calle D. Fakhrabadi-Shokoohi et al. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women Cancer Epidemiology Biomarkers and Prevention 2002 11
112. F. Lubin A. Chetrit L.S. Freedman et al. Body mass index at age 18 years and during adult life and ovarian cancer risk American Journal of Epidemiology 157 2003 113-120
113. A. Engeland S. Tretli T. Bjorge Height, body mass index, and ovarian cancer: A follow-up of 1.1 million Norwegian women Journal of the National Cancer Institute 95 2003 1244-1248
114. K.M. Fairfield W.C. Willett B.A. Rosner et al. Obesity, weight gain, and ovarian cancer Obstetrics and Gynecology 100 2002 288-296
115. A. Lukanova P. Toniolo E. Lundin et al. Body mass index in relation to ovarian cancer: A multi-centre nested case-control study International Journal of Cancer 99 2002 603-608
116. D.W. Cramer H. Xu Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer Annals of Epidemiology 5 1995 310-314
117. F. Parazzini E. Negri C. La Vecchia et al. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk Obstetrics and Gynecology 81 1993 363-366
118. S.A. Narod P. Sun P. Ghadirian et al. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: A case-control study Lancet 357 2001 1467-1470
119. R.E. Harris J. Beebe-Donk H. Doss D. Burr Doss Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: A critical review of non-selective COX-2 blockade (review) Oncology Reports 13 2005 559-583
120. K.M. Fairfield D.J. Hunter C.S. Fuchs et al. Aspirin, other NSAIDs, and ovarian cancer risk (United States) Cancer Causes and Control 13 2002 535-542
121. J.V. Lacey Jr M.E. Sherman P. Hartge et al. Medication use and risk of ovarian carcinoma: A prospective study International Journal of Cancer 108 2004 281-286
122. T.R. Rebbeck H.T. Lynch S.L. Neuhausen et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations The New England Journal of Medicine 346 2002 1616-1622
123. N.D. Kauff J.M. Satagopan M.E. Robson et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation The New England Journal of Medicine 346 2002 1609-1615
124. P.A. Meeuwissen C. Seynaeve C.T. Brekelmans et al. Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer Gynecologic Oncology 97 2005 476-482
125. R.I. Olivier M. van Beurden M.A. Lubsen et al. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up British Journal of Cancer 90 2004 1492-1497
126. M.S. Piver Prophylactic oophorectomy: Reducing the US Death rate from epithelial ovarian cancer. A continuing debate The Oncologist 1 1996 326-330
127. J. Nathorst-Boos B. von Schoultz K. Carlstrom et al. Elective ovarian removal and estrogen replacement therapy - effects on sexual life, psychological well-being and androgen status Journal of Psychosomatic Obstetrics and Gynaecology 14 1993 283-293
128. S.A. Everson K.A. Matthews D.S. Guzick et al. Effects of surgical menopause on psychological characteristics and lipid levels: The healthy women study Health Psychology 14 1995 435-443
129. B. Meiser K. Tiller M.A. Gleeson et al. Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer Psycho-oncology 9 2000 496-503
130. R.F. Ozols M.B. Daly A. Klein-Szanto et al. Chemoprevention of ovarian cancer: The journey begins Gynecologic Oncology 88 2003 S56-S59
131. G. Pichert B. Bolliger K. Buser O. Pagani Evidence-based management options for women at increased breast/ovarian cancer risk Annals of Oncology 14 2003 9-19
132. L.A. Keogh M.C. Southey J. Maskiell et al. Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study Cancer Epidemiology Biomarkers and Prevention 13 2004 2258-2263